Latest News

Stock markets trade lower in early deals amid ongoing Israel-Iran conflict

MMumbai, Jun 17 (PTI) Benchmark indices Sensex and Nifty declined in early trade on Tuesday amid profit-taking after recording a sharp rally in the previous session as investors turned cautious in view of the ongoing conflict between Israel and Iran. Investors also preferred staying on the sidelines ahead of the US Fed interest rate decision later this week, experts noted. The 30-share BSE Sensex declined 127.02 points to 81,669.13 in early trade. The 50-share NSE Nifty dipped 55 points to 24,891.50. From the 30-Sensex firms, IndusInd Bank, Tata Motors, Titan, Bajaj Finance, Sun Pharma and UltraTech Cement were among the

Rupee rises 11 paise to 85.93 against US dollar in early trade

Mumbai, Jun 17 (PTI) The rupee rose 11 paise to 85.93 against the US dollar in early trade on Tuesday defying pressures from a weak opening in the domestic markets, rise in global crude oil prices, and a stronger dollar. At the interbank foreign exchange, the rupee opened at 85.96 against the greenback before rising further to 85.93, up 11 paise from its previous close. The rupee had closed at 86.04 on Monday. “If rupee closes above 86.20 today (Tuesday) or any day the importers will have hit a stop loss as the gains for dollar could go up to

Air India chairman says crash should drive effort to build safer airline

NEW DELHI, June 16 (Reuters) – Air India’s Chairman N. Chandrasekaran on Monday told staff that last week’s plane crash that killed at least 271 people should be a catalyst to build a safer airline, urging employees to stay resolute amid any criticism. In a town hall held at the headquarters of the Tata Group-owned airline near New Delhi and attended by 700 staff, Chandrasekaran said the crash was the “most heartbreaking” crisis of his career, a spokesperson told Reuters. “I’ve seen a reasonable number of crises in my career, but this is the most heartbreaking one,” he said, according

New Obicetrapib cholesterol-lowering pill cuts heart attacks, strokes risk

Groundbreaking Study Reveals Obicetrapib’s Dual Benefits A new cholesterol-lowering pill, Obicetrapib, may revolutionize treatment for individuals at high risk of heart attacks and strokes. In a significant international study led by Monash University, researchers discovered that this once-daily oral medication effectively lowers both LDL cholesterol and Pill and lipoprotein (a), two major contributors to cardiovascular disease. The study, named the BROADWAY trial, involved more than 2,500 participants who were either diagnosed with existing heart conditions or had genetically high cholesterol levels. These patients were already receiving the maximum tolerated doses of traditional cholesterol-lowering drugs. Despite this, many continued to struggle

1 … 669 670 671 672 673 … 1,389